On this episode of Stock Movers:
- Verizon (VZ) shares jump after news the company is engaged in talks to sell some of its wireless spectrum to Verizon Communications Inc.
- Spotify (SPOT) shares drop after news that Chief Executive Officer Daniel Ek is stepping aside, leaving the leadership in the hands of Gustav Söderström and Alex Norström.
- Pfizer (PFE) shares rise after the Washington Post reported that President Donald Trump will announce an agreement with the drugmaker to voluntarily sell its medications through Medicaid at lower prices.

On this episode of Stock Movers: - Verizon (VZ) shares jump after news the company is engaged in talks to sell some of its wireless spectrum to Verizon Communications Inc. - Spotify (SPOT) shares drop after news that Chief Executive Officer Daniel Ek is stepping aside, leaving the leadership in the hands of Gustav S&ouml;derstr&ouml;m and Alex Norstr&ouml;m. - Pfizer (PFE) shares rise after the Washington Post reported that President Donald Trump will announce an agreement with the drugmaker to voluntarily sell its medications through Medicaid at lower prices.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Stock Movers: Verizon, Spotify, Pfizer (Podcast)

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/275def70-a787-4417-a2f6-b36800ff059f/transcript

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Barclays traders struggled to capitalize on a volatile quarter with returns falling short of their US rivals.
- Novartis’s profit fell more than estimated and sales unexpectedly declined in the first quarter as some of the drugmaker’s best-selling medicines were hit hard by generic competition. 
- WPP reported an organic sales decline of 6.7% in 1Q, higher than more pessimistic analyst forecasts.

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - Barclays traders struggled to capitalize on a volatile quarter with returns falling short of their US rivals. - Novartis&rsquo;s profit fell more than estimated and sales unexpectedly declined in the first quarter as some of the drugmaker&rsquo;s best-selling medicines were hit hard by generic competition. - WPP reported an organic sales decline of 6.7% in 1Q, higher than more pessimistic analyst forecasts.

Barclays Down, Novartis Falls, WPP Disappoints

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/a1f4e953-5b26-402a-aa4d-b43a00950ee6/transcript

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- BP said earnings jumped in the first quarter as spiraling energy prices and market turmoil triggered by the Iran war led to a surge in profits from its oil trading operation. 
- Barclays traders struggled to capitalize on a volatile quarter with returns falling short of their US rivals.
- Novartis’s profit fell more than estimated and sales unexpectedly declined in the first quarter as some of the drugmaker’s best-selling medicines were hit hard by generic competition.

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: - BP said earnings jumped in the first quarter as spiraling energy prices and market turmoil triggered by the Iran war led to a surge in profits from its oil trading operation. - Barclays traders struggled to capitalize on a volatile quarter with returns falling short of their US rivals. - Novartis&rsquo;s profit fell more than estimated and sales unexpectedly declined in the first quarter as some of the drugmaker&rsquo;s best-selling medicines were hit hard by generic competition.

BP Bonanza, Barclays Down, Novartis Falls

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/bbbddf80-f290-4854-ac35-b43a0089cbdc/transcript

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers: 
Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec.

- Micron Technology (MU) and Sandisk (SNDK) are both being started with buy ratings at Melius Research, which sees strong long-term tailwinds for the companies due to AI. The firm has a two-year price target of $1,350 for Sandisk, and a $700 target on Micron. MU gains 3.4%, SNDK is up +2.5%

- Veradermics (MANE) shares jump as much as 44% to hit its highest level since its February IPO, after the drug developer said its experimental oral therapy for male pattern hair loss met all primary and key secondary endpoints

- Walt Disney (DIS) shares fall as much as 0.4%, erasing an earlier gain, after President Donald Trump said the company should fire Jimmy Kimmel.

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Katie Greifeld, Carol Massar and Tim Stenovec. - Micron Technology (MU) and Sandisk (SNDK) are both being started with buy ratings at Melius Research, which sees strong long-term tailwinds for the companies due to AI. The firm has a two-year price target of $1,350 for Sandisk, and a $700 target on Micron. MU gains 3.4%, SNDK is up +2.5% - Veradermics (MANE) shares jump as much as 44% to hit its highest level since its February IPO, after the drug developer said its experimental oral therapy for male pattern hair loss met all primary and key secondary endpoints - Walt Disney (DIS) shares fall as much as 0.4%, erasing an earlier gain, after President Donald Trump said the company should fire Jimmy Kimmel.

Closing Bell: Micron/Sandisk Gain, Veradermics Surges, Disney Falls

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/de5e3e27-fa85-4bbf-9b0e-b439014db686/transcript

Stock Movers: Verizon, Spotify, Pfizer (Podcast)

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips